Evidence map›Paper›PMID 30813414›Full record

ReviewInternational journal of molecular sciences2019

Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications.

Valeria Gasperi, Matteo Sibilano, Isabella Savini, Maria Valeria Catani

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05648422 (Effect of the Nutritional Support System), which is not on this map. Cited by 132 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 1 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05648422 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Effect of the Nutritional Support System (NSS) on Neuromotor Alterations in Patients With Cerebral Palsy

TypeinterventionalSponsorAnahuac UniversityRan2023 to 2025Enrolled144ConditionsCerebral Palsy, Spastic, MalnutritionArmsProbiotics, NSS Nutritional Support System, Deworming, Specific diet, Conventional diet (WHO)
3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 1 synthesis or guideline pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Dual-Acting Vitamin BJournal of medicinal chemistry · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Restoring NADFrontiers in nutrition · 2026
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Valeria GasperiDepartment of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy. gasperi@med.uniroma2.it.
Matteo SibilanoDepartment of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy. matteosibilano@libero.it.
Isabella SaviniDepartment of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy. savini@uniroma2.it.
Maria Valeria CataniDepartment of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy. catani@uniroma2.it.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Niacin (also known as "vitamin B₃" or "vitamin PP") includes two vitamers (nicotinic acid and nicotinamide) giving rise to the coenzymatic forms nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). The two coenzymes are required for oxidative reactions crucial for energy production, but they are also substrates for enzymes involved in non-redox signaling pathways, thus regulating biological functions, including gene expression, cell cycle progression, DNA repair and cell death. In the central nervous system, vitamin B₃ has long been recognized as a key mediator of neuronal development and survival. Here, we will overview available literature data on the neuroprotective role of niacin and its derivatives, especially focusing especially on its involvement in neurodegenerative diseases (Alzheimer's, Parkinson's, and Huntington's diseases), as well as in other neuropathological conditions (ischemic and traumatic injuries, headache and psychiatric disorders).

Indexed as

Clinical Trials as TopicAnimalsCentral Nervous SystemHumansNervous System DiseasesNiacinNiacincentral nervous systemdietNAD(P)neurodegenerative diseasesniacinnicotinamidenicotinic acidvitamin B3

Identifiers

PMID30813414
PMCPMC6412771
OpenAlexW2915556067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.